trending Market Intelligence /marketintelligence/en/news-insights/trending/d3foth1mukoobn-bd6mzjg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Acerus Pharmaceuticals names CEO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Acerus Pharmaceuticals names CEO

Acerus Pharmaceuticals Corp. appointed Edward Gudaitis as president and CEO, effective May 1.

Luc Mainville will continue to act as interim CEO of the company and work with Gudaitis to ensure a smooth transition.

Following the transition, Mainville will resume his position as a board member.

Gudaitis most recently served as vice president and general manager of Allergan PLC's Allergan Canada.